知镜 Cognispect · 医学文献与研究工作台

Maternal oncostatin M levels in gestational diabetes mellitus: associations with metabolic dysfunction and pregnancy outcomes.

Kapudere B, Akdemir Y, Guven B.
Revista da Associacao Medica Brasileira (1992) · 2026-11-09 · PMID 43017951

文献摘要

Objective Gestational diabetes mellitus is characterized by metabolic dysfunction and altered inflammatory signaling. The aim of this study was to evaluate maternal serum oncostatin M levels in pregnancies complicated by gestational diabetes mellitus and explore their associations with metabolic and pregnancy outcomes. Methods In this prospective case-control study, 40 women with gestational diabetes mellitus and 40 healthy pregnant controls were enrolled. Maternal serum oncostatin M concentrations were measured during the third trimester using an enzyme-linked immunosorbent assay. Results Maternal serum oncostatin M levels were significantly lower in women with gestational diabetes mellitus than in controls (28.7 vs. 64.0 ng/L, p=0.001). Oncostatin M levels were negatively correlated with body mass index, insulin, hemoglobin A1c, and Homeostatic Model Assessment of Insulin Resistance, and positively correlated with gestational age at delivery (all p Conclusion Maternal oncostatin M levels are reduced in gestational diabetes mellitus and are associated with markers of metabolic dysfunction, supporting a potential association with the immunometabolic adaptations of diabetic pregnancy.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。